Eagle Veterinary Technology

이글벳 · 044960

Industrials Trading & Distribution · KOSDAQ

Small-cap

Market cap US$29.3M (₩40.5B)

Overview

Eagle Veterinary Technology makes and imports medicines for livestock and companion animals, including injectable drugs, water-soluble powders, feed additives, antibiotics, antiparasitic treatments, vitamins, and vaccines, used to prevent and treat disease in cattle, pigs, and poultry.

Its customers are livestock farmers and the broader Korean animal-husbandry supply chain. Listed on KOSDAQ, Korea's small-cap tech board, the company both manufactures and imports the full range of veterinary drug formats it supplies to the market.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$31.4M
▲ +3.9% YoY
Operating profit · FY2025
US$3.1M
▲ +22.9% YoY
Net income · FY2025
US$2.9M
▲ +6.5% YoY

Revenue

  • FY2023US$31M
  • FY2024US$30.2M
  • FY2025US$31.4M

Operating profit

  • FY2023US$2.4M
  • FY2024US$2.5M
  • FY2025US$3.1M

Net income

  • FY2023US$2.2M
  • FY2024US$2.7M
  • FY2025US$2.9M

Key ratios (FY2025)

ROE
7.6%
Debt/Eq
23.3%
Op. margin
9.8%
Net margin
9.1%
Rev. YoY
▲ +3.9%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.